Background: A severe acute respiratory virus that started lethal lung infections in Wuhan, China in Dec 2019 swiftly evolved into an epidemic in March 2020. Millions of fatalities have been attributed to COVID-19 globally, and people who survived the acute type often experience major mortality. Objective: The purpose of this research was to describe a number of patients who had experienced pulmonary problems following COVID-19. Methods: From December 2021 to June 2022, a retrospective research was done in Hayatabad Medical Complex, Peshawar. Patients with a record of a COVID-19 diagnosis verified by nasopharyngeal RT-PCR and who had been hospitalized to or visited an outpatient department were included. Results: This research included a total of 50 COVID-19 infected individuals. patients most frequently reported shortness of breath (n=29; 58%), fever (n=7; 14%), cough (n=5; 10%), and hemoptysis (n=9; 18%). Major surgical treatments were carried out on them, including bullectomies, lobectomies, and decortications and the most successful treatment for empyema is open decortication. Thirteen patients (26%) were admitted to the ICU after operations, nine cases (18%) acquired mucormycosis, and two deaths were reported.